Sign Up to like & get
recommendations!
1
Published in 2018 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.03.006
Abstract: Micro‐Abstract The HSD3B1 (1245C) variant is predictive of response to ADT in castration sensitive prostate cancer (CSPC) and to ketoconazole in castration resistant prostate cancer (CRPC). We hypothesized that the HSD3B1 (1245C) variant would be…
read more here.
Keywords:
response;
1245c variant;
prostate cancer;
castration ... See more keywords